Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemiaMathieu Wémeau, Nathalie Chaput|Cell Death and Disease|2010Cited by 119
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies: Insights from a large-scale NGS-based screening studyLeïla Ben Dhia, Nicolas Duployez, Laurène Fenwarth et al.|Blood|2025Cited by 0